https://pmc.ncbi.nlm.nih.gov/articles/PMC11507497/

Throughout the 3,000-year evolution of phlebotomy needles, material innovation has consistently been the driving force behind improvements in safety and effectiveness. From bronze to 316 stainless steel, and then to nickel-titanium shape-memory alloy, each material advancement corresponds to a leap in medical understanding and a revolution in manufacturing technology.

Exploring Materials in the Age of Metal

Ancient Egyptian bloodletting needles were typically made of flint or obsidian, which are naturally sharp but brittle, leading to the widespread use of bronze needles by 1500 BCE. During China's Shang Dynasty, bronze bloodletting needles contained 12–17% tin, balancing hardness and toughness. Iron bloodletting needles that emerged in ancient Greece were prone to rust and were often stored submerged in olive oil. Aristotle noted in his "Historia Animalium" that "iron needles turn dull when exposed to blood and must be tempered with fire."

Medieval Arabic alchemy brought a crucial breakthrough: Damascus steel, forged by folding Indian Wootz steel ingots, developed a distinctive pattern of iron carbide bands. Needles made from this steel could retain their sharpness through up to 200 punctures. In the 14th century, Moorish artisans in Cordoba, Spain, pioneered the "acid etching" technique, engraving bloodletting grooves and scales onto the surface of steel needles, enabling an initial quantification of bloodletting volume.

The Material Revolution Brought by the Industrial Revolution

In 1740, British inventor Huntsman developed the crucible steel process, producing homogeneous high-carbon steel and making mass production of lancets possible. Two technological breakthroughs in the mid-19th century transformed the industry: first, the Bessemer converter process introduced in 1856 reduced needle body costs by 80%; second, in 1868, British inventor Hunt developed nickel steel alloy with a tensile strength of 620 MPa, allowing needle tube wall thickness to be reduced by 40% without compromising strength.

The invention of stainless steel in 1913 was a milestone. While experimenting with gun barrel steels, Brearley discovered that an alloy containing 12% chromium did not corrode in nitric acid. In 1926, Germany's Krupp company developed 304 stainless steel (0Cr18Ni9), whose 18% chromium formed a dense oxide film and 8% nickel stabilized the austenitic structure, making it the dominant material for bloodletting needles by mid-20th century. However, clinical observations revealed that 304 still carried a risk of pitting corrosion in chlorinated disinfectants, prompting further material improvements.

Precision of Modern Medical Stainless Steel

The 316 stainless steel (0Cr17Ni12Mo2), developed in 1965, contains 2% molybdenum to resist chloride stress corrosion. The American ASTM F138 standard limits the carbon content of medical-grade 316L to below 0.03% to prevent intergranular corrosion. The Japanese JIS G4303 specification requires that needle bodies undergo solution annealing (quenched from 1040°C) to ensure complete dissolution of chromium carbide.

Dina GmbH of Germany developed a "martensitic时效 steel" in 2002, which, through multi-element alloying with titanium, aluminum, and molybdenum, achieves a hardness of HRC52 after aging at 580°C while maintaining 12% elongation. A 25G blood collection needle made from this material can withstand a bending force of 150N without plastic deformation, overcoming the traditional stainless steel limitation of being "hard yet brittle."

Disruptive Breakthroughs in Smart Materials

Nickel-titanium (NiTi) shape memory alloy offers new possibilities. When the needle is below its phase transition temperature (typically set at 28°C), it remains in a martensitic state with a hardness of only HV200, allowing it to bend up to 30° without breaking. Upon entering the body and warming to the austenitic state, its hardness increases to HV400, ensuring stable penetration. The SmartNeedle series, approved by the U.S. FDA in 2015, leverages this property to achieve intelligent response-soft and flexible at room temperature, rigid at body temperature.

Surface coating technology is equally critical: Hamilton's DLC (diamond-like carbon) coated needles, introduced in 2018, reduced the coefficient of friction from 0.6 to 0.1, decreasing puncture resistance by 40%; Terumo's fluorinated silane coating forms a nanoscale hydration layer that lowers blood surface tension to 32 mN/m, preventing blood from adhering to the needle walls.

A Paradigm Shift in Material Biocompatibility

Traditional material evaluation focuses on chemical inertness, while modern standards emphasize "biological response modulation." The EU ISO 10993-1 standard requires ten tests, including cytotoxicity, sensitization, and hemolysis. Research has shown that a hydroxyapatite coating on the surface of 316L stainless steel can increase fibroblast adhesion by threefold, promoting healing at puncture sites.

More promising is the exploration of biodegradable materials. In 2020, a magnesium-zinc-gadolinium alloy needle developed by the Fraunhofer Institute in Germany completely degraded within 60 days in the body, maintaining tensile strength for up to 21 days, making it suitable for patients with genetic disorders requiring repeated bloodletting. Meanwhile, a poly(ε-caprolactone)/hydroxyapatite composite needle developed by the Shenzhen Institutes of Advanced Technology in China controls a degradation period of 6–8 weeks by regulating crystallinity.

Cross-Disciplinary Integration of Future Materials

Graphene-reinforced composites are currently in the laboratory stage: researchers at the University of Manchester in the UK incorporated 0.1% graphene into 316L powder, producing a needle via selective laser melting 3D printing that achieves a 130% increase in thermal conductivity, enabling localized high-temperature sterilization upon puncture. Meanwhile, MIT has developed a liquid crystal elastomer-based needle capable of actively bending 15° under an electric field at 40°C, allowing for vessel-tracking puncture.

From a materials science perspective, the evolution of bloodletting needles is essentially a history of humanity's deepening understanding of the "metal-body" interface. Each material breakthrough enables us to regulate the interaction between medical devices and living systems at increasingly finer scales. This slender metal tube, no longer than an inch, is in fact a microcosm where materials science, clinical medicine, and biomechanics converge.